期刊
CELL METABOLISM
卷 20, 期 2, 页码 197-199出版社
CELL PRESS
DOI: 10.1016/j.cmet.2014.07.013
关键词
-
资金
- NIDDK NIH HHS [P01 DK049210] Funding Source: Medline
Metformin is the most widely prescribed drug to lower glucose in type II diabetics, yet its mechanism of action remains controversial. A new study reveals that metformin inhibits mitochondrial glycerol-3-phosphate dehydrogenase, triggering reduction of the cytosolic NADH/NAD(+) pool and impaired utilization of redox-dependent substrates for gluconeogenesis (Madiraju et al., 2014).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据